LRMR
Price
$2.15
Change
-$0.09 (-4.02%)
Updated
May 9, 03:59 PM (EDT)
Capitalization
143.42M
90 days until earnings call
UNCY
Price
$0.62
Change
-$0.02 (-3.12%)
Updated
May 8 closing price
Capitalization
75.04M
11 days until earnings call
Ad is loading...

LRMR vs UNCY

Header iconLRMR vs UNCY Comparison
Open Charts LRMR vs UNCYBanner chart's image
Larimar Therapeutics
Price$2.15
Change-$0.09 (-4.02%)
Volume$16.77K
Capitalization143.42M
Unicycive Therapeutics
Price$0.62
Change-$0.02 (-3.12%)
Volume$286.68K
Capitalization75.04M
LRMR vs UNCY Comparison Chart
Loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LRMR vs. UNCY commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a Hold and UNCY is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (LRMR: $2.24 vs. UNCY: $0.62)
Brand notoriety: LRMR and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 221% vs. UNCY: 34%
Market capitalization -- LRMR: $143.42M vs. UNCY: $75.04M
LRMR [@Biotechnology] is valued at $143.42M. UNCY’s [@Biotechnology] market capitalization is $75.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, LRMR is a better buy in the long-term than UNCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 5 TA indicator(s) are bullish while UNCY’s TA Score has 6 bullish TA indicator(s).

  • LRMR’s TA Score: 5 bullish, 5 bearish.
  • UNCY’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, UNCY is a better buy in the short-term than LRMR.

Price Growth

LRMR (@Biotechnology) experienced а -21.68% price change this week, while UNCY (@Biotechnology) price change was -4.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.07%. For the same industry, the average monthly price growth was +11.11%, and the average quarterly price growth was -13.36%.

Reported Earning Dates

LRMR is expected to report earnings on Aug 07, 2025.

UNCY is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (-5.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($143M) has a higher market cap than UNCY($75M). UNCY YTD gains are higher at: -21.670 vs. LRMR (-42.119). UNCY has higher annual earnings (EBITDA): -22.56M vs. LRMR (-73.44M). LRMR has more cash in the bank: 204M vs. UNCY (32.3M). UNCY has less debt than LRMR: UNCY (807K) vs LRMR (5.36M). LRMR (0) and UNCY (0) have equivalent revenues.
LRMRUNCYLRMR / UNCY
Capitalization143M75M191%
EBITDA-73.44M-22.56M326%
Gain YTD-42.119-21.670194%
P/E RatioN/AN/A-
Revenue00-
Total Cash204M32.3M632%
Total Debt5.36M807K664%
FUNDAMENTALS RATINGS
LRMR: Fundamental Ratings
LRMR
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LRMRUNCY
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BFH50.471.82
+3.74%
Bread Financial Holdings
MLP14.880.11
+0.74%
Maui Land & Pineapple Co
TM187.92-0.98
-0.52%
Toyota Motor Corp
WF37.83-0.28
-0.73%
Woori Financial Group
MCRB6.95-1.33
-16.10%
Seres Therapeutics Inc

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with ERAS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+3.23%
ERAS - LRMR
49%
Loosely correlated
+13.47%
SVRA - LRMR
49%
Loosely correlated
+5.23%
IMNM - LRMR
47%
Loosely correlated
+3.77%
IDYA - LRMR
47%
Loosely correlated
+1.96%
SYRE - LRMR
46%
Loosely correlated
+1.18%
More

UNCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with IRD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then IRD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
-2.35%
IRD - UNCY
35%
Loosely correlated
-2.37%
VKTX - UNCY
35%
Loosely correlated
+1.05%
BBIO - UNCY
32%
Poorly correlated
-2.71%
ROIV - UNCY
27%
Poorly correlated
-1.25%
LRMR - UNCY
27%
Poorly correlated
+3.23%
More